ARCHIVES

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

Five Group Chairs Discuss Mergers In A Q&A

March 11, 2011

Randomized Trial Finds Sunscreen Use Cuts Risk Of Developing Melanoma

December 31, 2010

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

In Brief: Stephen Schimpff Accepts New Position Of Executive Vice President Of Univ. Of Maryland Medical System

October 4, 1985

Centers Network Release “Version 1.0” Of Clinical Guidelines for Eight Cancers

March 15, 1996